title: Indications and limitations of afamelanotide for treating vitiligo-reply.
authors.affiliation: Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
authors.forename: Henry W
authors.initials: HW
authors.lastname: Lim
authors.affiliation: Vitiligo and Pigmentation Institute of Southern California, Los Angeles.
authors.forename: Pearl E
authors.initials: PE
authors.lastname: Grimes
authors.affiliation: Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Mark
authors.initials: M
authors.lastname: Lebwohl
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D014467:Ultraviolet Therapy / Q000379:methods*; D014820:Vitiligo / Q000628:therapy*; D000521:alpha-MSH / Q000031:analogs & derivatives*
chemical_list: D000521:alpha-MSH